2-Pyrrolidinecarboxylic acid, 1-(2-phenylethyl)-, methyl ester

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-Pyrrolidinecarboxylic acid, 1-(2-phenylethyl)-, methyl ester
• 英文别名: methyl 1-(2-phenylethyl)pyrrolidine-2-carboxylate
• 化学式: C₁₄H₁₉NO₂
• 分子量: 233.31
• InChiKey: NTUORBPSIHMIFV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Esterase genes and uses of the same
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP1057894A2

  公开（公告）日：2000-12-06

  The present invention provides a novel gene encoding a protein having an excellent catalyst ability for producing (S)-N-substituted cyclic imino acid represented by the general formula (2) (= the (S)-cyclic imino acid (2)): and to provide a novel method for producing the (S)-cyclic imino acid (2) by an asymmetric hydrolization of the N-substituted cyclic imino acid ester represented by the general formula (1): in a manner of gene engineering technology utilizing the novel gene provided.

  本发明提供了一种新型基因，该基因编码的蛋白质在生产通式(2)代表的(S)-N-取代环 亚胺酸(=(S)-环亚胺酸(2))方面具有优异的催化能力： 并提供一种通过通式(1)代表的 N-取代环亚胺酸酯的不对称水解生产 (S)-环亚胺酸(2)的新方法： 以基因工程技术的方式利用所提供的新型基因。
• Antiviral compounds
  申请人：HAPLOGEN GMBH

  公开号：US11091428B2

  公开（公告）日：2021-08-17

  The present invention relates to novel compounds of general formula (I) wherein the groups X, and R1 to R4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.

  本发明涉及通式(I)的新型化合物（其中基团X和R1至R4的含义见说明书和权利要求书）、制备这些化合物的工艺及其用于治疗、预防或改善病毒感染的用途，以及用于治疗、预防或改善与PLA2G16有关的疾病的用途。
• Esterace genes and uses of the same
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：US20020173013A1

  公开（公告）日：2002-11-21

  The present invention provides a novel gene encoding a protein having an excellent catalyst ability for producing (S)-N-substituted cyclic imino acid represented by the general formula (2) (=the (S)-cyclic imino acid (2)): 1 and to provide a novel method for producing the (S)-cyclic imino acid (2) by an asymmetric hydrolization of the N-substituted cyclic imino acid ester represented by the general formula (1): 2 in a manner of gene engineering technology utilizing the novel gene provided.

  本发明提供了一种新型基因，该基因编码的蛋白质在生产通式(2)代表的(S)-N-取代环亚胺酸(&等于;(S)-环亚胺酸(2))方面具有优异的催化能力： 1 并提供一种通过通式(1)代表的 N-取代环亚胺酸酯的不对称水解生产(S)-环亚胺酸(2)的新方法： 2 以基因工程技术的方式利用所提供的新型基因。
• ANTIVIRAL COMPOUNDS
  申请人：HAPLOGEN GMBH

  公开号：US20190225575A1

  公开（公告）日：2019-07-25

  The present invention relates to novel compounds of general formula (I) wherein the groups X, and R 1 to R 4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.
• US6537790B1
  申请人：——

  公开号：US6537790B1

  公开（公告）日：2003-03-25